利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

76 条记录 (耗时 0.034 秒)

    Imidazolidinedione derivatives and use thereof as drugs
    1.
    发明授权
    Imidazolidinedione derivatives and use thereof as drugs 失效
    咪唑烷二酮衍生物及其作为药物的用途

    公开(公告)号：US06919365B2

    公开(公告)日：2005-07-19

    申请号：US10473889

    申请日：2002-04-08

    申请人： Yusuke Sakai ,  Jun Inoue

    发明人： Yusuke Sakai ,  Jun Inoue

    IPC分类号： C07D233/72 ,  C07D233/80 ,  C07D235/02 ,  C07D263/44 ,  C07D413/06 ,  A61K31/4166 ,  C07D233/74

    CPC分类号： C07D235/02 ,  C07D233/80 ,  C07D263/44 ,  C07D413/06

    摘要： The present invention is to provide an imidazolidinedione derivative and oxazolidinedione derivative represented by the following general Formula (I) having the chymase and/or tryptase inhibition activity [wherein R1 and R2 are the same or different, and denote a lower alkyl group or a phenyl group, or R1 and R2 are taken together to form a ring, R3 denotes an optionally substituted naphthyl group or heterocyclic group, A denotes oxygen or NR4 (R4 is hydrogen or optionally substituted lower alkyl group), or NB2R5 (R5 is aryl group, and B2 is carbonyl group or sulfonyl group), and B1 denotes a carbonyl group or a sulfonyl group], or a pharmaceutically acceptable salt thereof.

    摘要翻译： 本发明提供由具有糜酶和/或类胰蛋白酶抑制活性的其他通式（I）表示的咪唑烷二酮衍生物和恶唑烷二酮衍生物[其中R 1和R 2， >相同或不同，表示低级烷基或苯基，或R 1和R 2一起形成环，R“ 3表示任选取代的萘基或杂环基，A表示氧或NR 4（R 4）是氢或任选取代的低级烷基）或NB （R 5是芳基，B 2是羰基或磺酰基），和 B 1表示羰基或磺酰基]或其药学上可接受的盐。

    Pharmaceutical containing PPAR delta agonist
    2.
    发明授权
    Pharmaceutical containing PPAR delta agonist 有权
    含有PPARδ激动剂的药物

    公开(公告)号：US08802705B2

    公开(公告)日：2014-08-12

    申请号：US12451564

    申请日：2008-05-20

    申请人： Yoshikuni Nakamura ,  Ikuko Hanano ,  Jun Inoue

    发明人： Yoshikuni Nakamura ,  Ikuko Hanano ,  Jun Inoue

    IPC分类号： A61K31/422 ,  A61K31/427

    CPC分类号： A61K31/427 ,  A61K31/421 ,  A61K31/426 ,  C07D263/32 ,  C07D277/24 ,  C07D417/06

    摘要： Provision of an agent for promoting proliferation of meibomian gland epithelial cells or corneal epithelial cells, and a therapeutic agent for ocular diseases such as meibomian gland dysfunction, dry eye and the like.A preparation containing [3-[2-[4-isopropyl-2-(4-trifluoromethyl)phenyl-5-thiazolyl]ethyl]-5-methyl-1,2-benzisoxazol-6-yl]oxyacetic acid, [4-[3-[2-(4-trifluoromethyl)phenyl-4-isopropyl-5-thiazolyl]propionyl]-2-methylphenoxy]acetic acid or [4-[3-[2-(2-hydroxy-4-chlorophenyl)-5-isopropyl-4-oxazolyl]propionyl]-2-methylphenoxy]acetic acid, or a pharmacologically acceptable salt thereof as an active ingredient is used as an agent for promoting proliferation of meibomian gland epithelial cells or corneal epithelial cells, as well as a therapeutic agent for ocular diseases such as meibomian gland dysfunction, dry eye and the like.

    摘要翻译： 提供用于促进睑板腺上皮细胞或角膜上皮细胞增殖的药剂，以及眼部疾病如睑板腺功能障碍，干眼症等的治疗剂。 含有[3- [2- [4-异丙基-2-（4-三氟甲基）苯基-5-噻唑基]乙基] -5-甲基-1,2-苯并异恶唑-6-基]氧基乙酸[4- [3- [2-（4-三氟甲基）苯基-4-异丙基-5-噻唑基]丙酰] -2-甲基苯氧基]乙酸或[4- [3- [2-（2-羟基-4-氯苯基） 5-异丙基-4-恶唑基]丙酰基] -2-甲基苯氧基]乙酸或其药理学上可接受的盐作为活性成分用作促进睑板腺上皮细胞或角膜上皮细胞增殖的试剂，以及 诸如睑板腺功能障碍，干眼症等眼部疾病的治疗剂。

    Method for detecting neuroblastoma
    3.
    发明授权
    Method for detecting neuroblastoma 有权
    神经母细胞瘤检测方法

    公开(公告)号：US08216785B2

    公开(公告)日：2012-07-10

    申请号：US12568569

    申请日：2009-09-28

    申请人： Johji Inazawa ,  Issei Imoto ,  Jun Inoue

    发明人： Johji Inazawa ,  Issei Imoto ,  Jun Inoue

    IPC分类号： C12Q1/68 ,  G01N33/53

    CPC分类号： G01N33/57407 ,  A61K38/00 ,  C12Q1/6886 ,  C12Q2600/154

    摘要： The present invention is intended to provide a means for judging the malignancy of neuroblastoma and the progress of spontaneous regression thereof. The present invention provides a method for detecting cancer which comprises detecting activation or inactivation of the lysosomal-associated protein multispanning transmembrane 5 (LAPTM5) gene and amplification of the MYCN gene in a specimens to evaluate the malignancy of the specimens and the progress of spontaneous regression.

    摘要翻译： 本发明旨在提供一种判断神经母细胞瘤的恶性程度及其自发消退的方法。 本发明提供一种检测癌症的方法，其包括检测样品中溶酶体相关蛋白多能跨膜5（LAPTM5）基因的活化或失活以及MYCN基因的扩增，以评估标本的恶性程度和自发回归的进展 。

    OPTICALLY ACTIVE DIFLUOROMETHANESULFONANILIDE DERIVATIVE AND HERBICIDE
    4.
    发明申请
    OPTICALLY ACTIVE DIFLUOROMETHANESULFONANILIDE DERIVATIVE AND HERBICIDE 审中-公开
    光学活性二聚异氰脲酸衍生物和除草剂

    公开(公告)号：US20110178299A1

    公开(公告)日：2011-07-21

    申请号：US13120800

    申请日：2009-06-10

    申请人： Jun Inoue ,  Hiroshi Kawasaki ,  Sohei Asakura

    发明人： Jun Inoue ,  Hiroshi Kawasaki ,  Sohei Asakura

    IPC分类号： C07D239/52

    CPC分类号： C07D239/52 ,  A01N43/54

    摘要： The present invention aims at providing an optically active difluoromethanesulfonanilide derivative exhibiting an excellent herbicidal activity at a low dose.An optically active (R)-2′-(4,6-dimethoxy-pyrimidin-2-yl)hydroxymethyl-1,1-difluoromethanesulfonanilide derivative is represented by the formula (I) (in the formula, R1 is a hydrogen atom, a C1-C4 alkyl group or a C1-C4 alkoxy C1-C4 alkyl group). and this difluoromethanesulfonanilide derivative is produced by subjecting to optical resolution a racemate of 2′-(4,6-dimethoxypyrimidin-2-yl)hydroxymethyl-1,1-difluoromethanesul-fonanilide derivative.

    摘要翻译： 本发明的目的在于提供一种在低剂量下表现出优异除草活性的光学活性二氟甲磺酰苯胺衍生物。 光学活性（R）-2' - （4,6-二甲氧基 - 嘧啶-2-基）羟甲基-1,1-二氟甲磺酰苯胺衍生物由式（I）表示（式中，R1是氢原子， C1-C4烷基或C1-C4烷氧基C1-C4烷基）。 该二氟甲磺酰苯胺衍生物是通过光学拆分2' - （4,6-二甲氧基嘧啶-2-基）羟甲基-1,1-二氟甲磺酰氟苯胺衍生物的外消旋物制得的。

    Optical signal transmission device
    7.
    发明授权
    Optical signal transmission device 失效
    光信号传输装置

    公开(公告)号：US07228073B2

    公开(公告)日：2007-06-05

    申请号：US10615394

    申请日：2003-07-09

    申请人： Jun Inoue ,  Hideyuki Sotobayashi ,  Wataru Chujo ,  Hitoshi Kawaguchi

    发明人： Jun Inoue ,  Hideyuki Sotobayashi ,  Wataru Chujo ,  Hitoshi Kawaguchi

    IPC分类号： H04J4/00 ,  H04J14/08 ,  H04B10/08

    CPC分类号： H04J14/08

    摘要： An optical signal transmission device for transmitting phase information of optical signals is provided. The device includes a multiplexing formatted optical signal generator arranged to generate multiplexing formatted optical signals. The device also includes an optical phase generator arranged to receive the multiplexing formatted optical signals. An optical information transmission method for transmitting optical signal information including phase information is also provided. The method includes receiving multiplexing formatted optical signals generated by a multiplexing formatted optical signal generator at an optical phase generator. The method also includes phase conjugating the multiplexing formatted optical signals by means of four wave mixing (FWM).

    摘要翻译： 提供一种用于发送光信号的相位信息的光信号传输装置。 该设备包括多路复用格式化的光信号发生器，被布置为产生复用格式化的光信号。 该装置还包括光学相位发生器，其布置成接收复用格式化的光信号。 还提供了一种用于发送包括相位信息的光信号信息的光信息传输方法。 该方法包括在光相位发生器处接收由复用格式化的光信号发生器产生的格式化的光信号复用。 该方法还包括通过四波混频（FWM）将复用格式化的光信号相位共轭。

    Angiogenesis inhibitor
    9.
    发明授权
    Angiogenesis inhibitor 失效
    血管生成抑制剂

    公开(公告)号：US06214800B1

    公开(公告)日：2001-04-10

    申请号：US09282501

    申请日：1999-04-09

    申请人： Chiho Fukiage ,  Mitsuyoshi Azuma ,  Jun Inoue ,  Masayuki Nakamura ,  Yuka Yoshida

    发明人： Chiho Fukiage ,  Mitsuyoshi Azuma ,  Jun Inoue ,  Masayuki Nakamura ,  Yuka Yoshida

    IPC分类号： A61K3800

    CPC分类号： A61K38/55 ,  C07C311/19 ,  C07D303/48

    摘要： An angiogenesis inhibitor comprising a cysteine protease inhibitory compound. As the preferable cysteine protease inhibitory compound, epoxysuccinic acid compounds, peptide halohydrazide compounds, calpain inhibitory compounds, compounds of the formula (I) and compounds of the formula (VI) can be used. The angiogenesis inhibitor of the present invention suppresses new formation of blood vessels in the living tissues, so that it can be used as a superior therapeutic or prophylactic agent of angiogenesis associated with wound healing, inflammation, growth of tumor and the like; and angiogenesis as seen in diabetic retinopathy, prematurity retinopathy, retinal venous occlusion, senile discoid macular degeneration and the like, as well as for prevention of metastasis of tumors.

    摘要翻译： 一种包含半胱氨酸蛋白酶抑制化合物的血管生成抑制剂。 作为优选的半胱氨酸蛋白酶抑制化合物，可以使用环氧琥珀酸化合物，肽卤代酰肼化合物，钙蛋白酶抑制化合物，式（I）的化合物和式（VI）的化合物。 本发明的血管发生抑制剂抑制活组织中血管的新形成，可以用作与伤口愈合，炎症，肿瘤生长等有关的血管生成的优异治疗或预防剂。 和血管生成，如糖尿病视网膜病变，早产儿视网膜病变，视网膜静脉闭塞，老年性盘状黄斑变性等，以及用于预防肿瘤转移。

    Bicycle suspension having stroke and damper adjustment
    10.
    发明授权
    Bicycle suspension having stroke and damper adjustment 有权
    具有行程和阻尼器调节的自行车悬架

    公开(公告)号：US08317171B2

    公开(公告)日：2012-11-27

    申请号：US12101600

    申请日：2008-04-11

    申请人： Jun Inoue

    发明人： Jun Inoue

    IPC分类号： B60G13/00 ,  B62K1/00

    CPC分类号： B62K25/08 ,  B62K2025/047 ,  B62K2025/048 ,  F16F9/461 ,  F16F9/56

    摘要： A bicycle suspension including a stroke adjustment unit, a suspension damper, and a damper adjustment unit. The stroke adjustment unit is configured to adjust a stroke of the bicycle suspension, which is configured to expand and contract within the stroke. The suspension damper is configured to apply damping force to the bicycle suspension, and the damper adjustment unit is configured to adjust the damping force applied by the suspension damper in accordance with the stroke adjusted by the stroke adjustment unit.

    摘要翻译： 一种自行车悬架，包括行程调节单元，悬架阻尼器和阻尼器调节单元。 行程调节单元构造成调节自行车悬架的行程，该行程构造成在行程内膨胀和收缩。 悬架阻尼器构造成对自行车悬架施加阻尼力，并且阻尼器调节单元构造成根据由行程调节单元调节的行程来调节由悬架阻尼器施加的阻尼力。